Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Sensors (Basel) ; 23(21)2023 Nov 01.
Article in English | MEDLINE | ID: mdl-37960588

ABSTRACT

Accurately calibrating camera-LiDAR systems is crucial for achieving effective data fusion, particularly in data collection vehicles. Data-driven calibration methods have gained prominence over target-based methods due to their superior adaptability to diverse environments. However, current data-driven calibration methods are susceptible to suboptimal initialization parameters, which can significantly impact the accuracy and efficiency of the calibration process. In response to these challenges, this paper proposes a novel general model for the camera-LiDAR calibration that abstracts away the technical details in existing methods, introduces an improved objective function that effectively mitigates the issue of suboptimal parameter initialization, and develops a multi-level parameter optimization algorithm that strikes a balance between accuracy and efficiency during iterative optimization. The experimental results demonstrate that the proposed method effectively mitigates the effects of suboptimal initial calibration parameters, achieving highly accurate and efficient calibration results. The suggested technique exhibits versatility and adaptability to accommodate various sensor configurations, making it a notable advancement in the field of camera-LiDAR calibration, with potential applications in diverse fields including autonomous driving, robotics, and computer vision.

2.
Curr Cancer Drug Targets ; 23(1): 2-14, 2022.
Article in English | MEDLINE | ID: mdl-35946101

ABSTRACT

Since their discovery, saikosaponins (SSs) have been found to play an important role in treating a variety of cancers via diverse mechanisms of action. This review summarizes the current research status and prospects of the anti-cancer activities of SSs, providing novel insights into the limitations of current studies. In addition, it discusses whether SSs can be applied in immunotherapy and the possible mechanisms by which SSs may facilitate immunotherapy. The research is significant to understanding the anti-cancer potents of SSs in the development of SSs-based therapeutic strategies and clinical practice.


Subject(s)
Drugs, Chinese Herbal , Neoplasms , Oleanolic Acid , Saponins , Humans , Saponins/pharmacology , Saponins/therapeutic use , Oleanolic Acid/pharmacology , Oleanolic Acid/therapeutic use , Neoplasms/drug therapy
3.
PLoS One ; 16(3): e0246393, 2021.
Article in English | MEDLINE | ID: mdl-33690604

ABSTRACT

Evidence link bacterial enterotoxins to apparent crypt-cell like cells (CCLCs), and Alpha Defensin 5 (DEFA5) expansion in the colonic mucosa of Crohn's colitis disease (CC) patients. These areas of ectopic ileal metaplasia, positive for Paneth cell (PC) markers are consistent with diagnosis of CC. Retrospectively, we: 1. Identified 21 patients with indeterminate colitis (IC) between 2000-2007 and were reevaluation their final clinical diagnosis in 2014 after a followed-up for mean 8.7±3.7 (range, 4-14) years. Their initial biopsies were analyzed by DEFA5 bioassay. 2. Differentiated ulcer-associated cell lineage (UACL) analysis by immunohistochemistry (IHC) of the CC patients, stained for Mucin 6 (MUC6) and DEFA5. 3. Treated human immortalized colonic epithelial cells (NCM460) and colonoids with pure DEFA5 on the secretion of signatures after 24hr. The control colonoids were not treated. 4. Treated colonoids with/without enterotoxins for 14 days and the spent medium were collected and determined by quantitative expression of DEFA5, CCLCs and other biologic signatures. The experiments were repeated twice. Three statistical methods were used: (i) Univariate analysis; (ii) LASSO; and (iii) Elastic net. DEFA5 bioassay discriminated CC and ulcerative colitis (UC) in a cohort of IC patients with accuracy. A fit logistic model with group CC and UC as the outcome and the DEFA5 as independent variable differentiator with a positive predictive value of 96 percent. IHC staining of CC for MUC6 and DEFA5 stained in different locations indicating that DEFA5 is not co-expressed in UACL and is therefore NOT the genesis of CC, rather a secretagogue for specific signature(s) that underlie the distinct crypt pathobiology of CC. Notably, we observed expansion of signatures after DEFA5 treatment on NCM460 and colonoids cells expressed at different times, intervals, and intensity. These factors are key stem cell niche regulators leading to DEFA5 secreting CCLCs differentiation 'the colonic ectopy ileal metaplasia formation' conspicuously of pathogenic importance in CC.


Subject(s)
Colitis, Ulcerative/metabolism , Colon/cytology , Crohn Disease/metabolism , Enterotoxins/pharmacology , Organoids/cytology , alpha-Defensins/metabolism , Aged , Cell Lineage , Cells, Cultured , Colitis, Ulcerative/microbiology , Colitis, Ulcerative/pathology , Colon/drug effects , Colon/metabolism , Crohn Disease/microbiology , Crohn Disease/pathology , Epithelial Cells/cytology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Female , Humans , Logistic Models , Male , Mucin-6/metabolism , Organ Culture Techniques , Organoids/drug effects , Organoids/metabolism , Proteomics , Retrospective Studies
4.
Zhongguo Zhong Yao Za Zhi ; 45(18): 4349-4357, 2020 Sep.
Article in Chinese | MEDLINE | ID: mdl-33164362

ABSTRACT

The plants of genus Clinopodium are perennial herbs of Labiatae, which are widely distributed in the world and have a promising medicinal value. Modern researches have shown flavonoids, triterpenoid saponins, terpene glycosides, terpenoids, volatile oils and phenylpropanoids are the main compounds in the plants, presenting various pharmacological effects such as hemostasis, anti-bacteria, anti-inflammation, immunoregulation, reducing blood glucose, antioxidation, and anti-tumor effects. The preparations made of those plants are mainly used for treatment of various bleeding diseases in clinical application. In this review, we systematically summarized the research progress on taxonomy, resource distribution, chemical compositions, pharmacological activities, and clinical application of the medicinal plants of genus Clinopodium. This review provides references and scientific basis for further research and development of genus Clinopodium.


Subject(s)
Lamiaceae , Plants, Medicinal , Flavonoids , Phytochemicals , Plant Extracts
5.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-872900

ABSTRACT

Qizhu, the dried rhizome of Atractylodes macrocephala in Compositae family, is the representative wild variety of Atractylodis Macrocephalae Rhizoma (Baizhu) with modern excellent quality. Through textual research of materia medica works and modern studies, the medication methods between Qizhu and ancient Baizhu were systematically compared. Focusing on seven key issues, this paper systematically summarized the medicinal history, characters, cultivation and other related contents of Qizhu, in order to provide a basis of Qizhu in the recovery and development of its own Daodi-status, and further serve the industrial development of this herb. The name, harvesting time, processing method and other issues had undergone a relatively complicated evolution process. At present, acknowledged points are as following:①The distribution areas of Qizhu include southern areas of the Yangtze River in Anhui province and its surrounding regions. ②Harvesting time is late October. ③Qizhu can be dried in the shade or micro-hot dried after being wrapped with absorbent paper, later it can be divided into two commercial specifications. ④In addition to cutting, there is still a lack of other processing methods. ⑤The superior characters of Qizhu contain white, less oil, fragrant smell and sweet taste and so on. ⑥The history of Qizhu as a genuine medicinal material can be traced back to the Ming dynasty.

7.
Nan Fang Yi Ke Da Xue Xue Bao ; 37(7): 866-868, 2017 Jul 20.
Article in Chinese | MEDLINE | ID: mdl-28736359

ABSTRACT

Small intestinal hemangioma is a rare condition that can be divided histologically into capillary, cavernous or mixed types, among which the cavernous type is the most common. Here we report a case of small intestinal cavernous hemangioma with chronic hemorrhage in 44-year-old man. The patient complained of weakness and dizziness for 2 years that aggravated 1 month before admission accompanied by intermittent melena. Laboratory tests suggest severe anemia, and computed tomography, gastroscopy and colonoscopy all revealed signs of anemia. Capsule endoscopy detected small intestinal erosions, bleeding lesions and prominent neoplasms. An exploratory laparotomy was performed, in which the segment of the jejunum with lesions was resected. Pathological examination of the resected jejunum identified the neoplasm as cavernous hemangioma of the small intestine, which was the cause of severe anemia.

8.
Chemotherapy ; 62(5): 290-294, 2017.
Article in English | MEDLINE | ID: mdl-28490007

ABSTRACT

Duodenal bulb adenocarcinoma is an extremely rare malignancy in the alimentary tract which has a low incidence rate and nonspecific symptoms. It is difficult to diagnose early, and the misdiagnosis rate is high. CT, MRI, upper gastrointestinal endoscopy, and other advanced imaging modalities should be combined to make a comprehensive evaluation. The diagnostic confirmation of this tumor type mainly depends on the pathological examination. The combination of surgery with other treatment modalities is effective. A review of reports on duodenal bulb adenocarcinoma with chemotherapy revealed 6 cases since 1990. However, there are few reports on neoadjuvant chemotherapy for the disease. In this report, preoperative S-1 in combination with oxaliplatin neoadjuvant chemotherapy achieved a complete pathological response in the treatment of duodenal bulb adenocarcinoma. Neoadjuvant chemotherapy shows a better clinical efficacy in the treatment of duodenal bulb adenocarcinoma, but its value needs to be further verified.


Subject(s)
Adenocarcinoma/therapy , Duodenal Neoplasms/therapy , Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Duodenal Neoplasms/drug therapy , Duodenal Neoplasms/pathology , Duodenum/pathology , Endoscopy, Gastrointestinal , Humans , Male , Middle Aged , Neoadjuvant Therapy , Organoplatinum Compounds/therapeutic use , Oxaliplatin , Tomography, X-Ray Computed
9.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-360172

ABSTRACT

Small intestinal hemangioma is a rare condition that can be divided histologically into capillary, cavernous or mixed types, among which the cavernous type is the most common. Here we report a case of small intestinal cavernous hemangioma with chronic hemorrhage in 44-year-old man. The patient complained of weakness and dizziness for 2 years that aggravated 1 month before admission accompanied by intermittent melena. Laboratory tests suggest severe anemia, and computed tomography, gastroscopy and colonoscopy all revealed signs of anemia. Capsule endoscopy detected small intestinal erosions, bleeding lesions and prominent neoplasms. An exploratory laparotomy was performed, in which the segment of the jejunum with lesions was resected. Pathological examination of the resected jejunum identified the neoplasm as cavernous hemangioma of the small intestine, which was the cause of severe anemia.

10.
J Am Heart Assoc ; 4(11)2015 Nov 05.
Article in English | MEDLINE | ID: mdl-26541392

ABSTRACT

BACKGROUND: Flow-mediated dilation (FMD) is used to assess endothelial function through changes in vascular diameter after hyperemia. High-fat meal (HFM) has been shown to induce endothelial dysfunction; recent studies, however, reported conflicting results in obese African American women (AAW). Differences in the method used to analyze FMD may explain these discrepancies. METHODS AND RESULTS: In protocol 1, we assessed the time course of FMD and compared the repeatability of FMD using the individual maximum peak dilation (FMDpeak) and the dilation at 60 seconds (FMD60). Sixteen AAW (age, 42±10.4 years; body mass index [BMI], 39±5.8 kg/m(2)) were studied on 2 occasions, 4 weeks apart, under fasting conditions (study 1 and study 2). In protocol 2, we used the most repeatable measurement from protocol 1 to assess changes in endothelial function after an HFM in 17 AAW (agen 42±11.1 years; BMIn 38±5.6 kg/m(2)). We found that FMDpeak was the most repeatable measurement (N=16; study 1, 5.31±3.12% and study 2, 5.80±2.91%; r=0.94). After an HFM, the baseline brachial artery diameter significantly increased at 2 hours (0.10 mm; 95% confidence interval [CI], 0.01-0.18; P=0.03) and at 4 hours (0.17 mm; 95% CI, 0.09-0.25; P<0.001). At 2 hours, the FMDpeak decreased compared with pre-HFM (-1.76; 95% CI, -3.55-0.02; P≤0.05). CONCLUSIONS: The individual's maximum peak dilation after hyperemia is the most consistent measure to assess the effect of an HFM on endothelial function. Endothelial dysfunction occurred at 2 hours after an HFM in AAW. CLINICAL TRIAL REGISTRATION: URL: https://clinicaltrials.gov/ Unique identifiers: NCT01334554 and NCT02126735.


Subject(s)
Black or African American , Brachial Artery/physiopathology , Diet, High-Fat/adverse effects , Endothelium, Vascular/physiopathology , Meals , Obesity/physiopathology , Vasodilation , Adult , Body Mass Index , Brachial Artery/diagnostic imaging , Endothelium, Vascular/diagnostic imaging , Female , Humans , Hyperemia/physiopathology , Male , Middle Aged , Obesity/diagnostic imaging , Obesity/ethnology , Predictive Value of Tests , Regional Blood Flow , Reproducibility of Results , Time Factors , Ultrasonography
11.
Prostaglandins Other Lipid Mediat ; 113-115: 38-44, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25173047

ABSTRACT

Epoxyeicosatrienoic acids (EETs) protect against the development of insulin resistance in rodents. EETs are hydrolyzed to less biologically active diols by soluble epoxide hydrolase (encoded for by EPHX2). Functional variants of EPHX2 encode for enzymes with increased (Lys55Arg) or decreased (Arg287Gln) hydrolase activity. This study tested the hypothesis that variants of EPHX2 are associated with insulin sensitivity or secretion in humans. Subjects participating in metabolic phenotyping studies were genotyped. Eighty-five subjects underwent hyperglycemic clamps. There was no relationship between the Lys55Arg genotype and insulin sensitivity or secretion. In contrast, the EPHX2 287Gln variant was associated with higher insulin sensitivity index (p=0.019 controlling for body mass index and metabolic syndrome). Also, there was an interactive effect of EPHX2 Arg287Gln genotype and body mass index on insulin sensitivity index (p=0.029). There was no relationship between EPHX2 Arg287Gln genotype and acute or late-phase glucose-stimulated insulin secretion, but disposition index was higher in 287Gln carriers compared with Arg/Arg (p=0.022). Plasma EETs correlated with insulin sensitivity index (r=0.64, p=0.015 for total EETs) and were decreased in the metabolic syndrome. A genetic variant that results in decreased soluble epoxide hydrolase activity is associated with increased insulin sensitivity, as are higher EETs.


Subject(s)
Arachidonic Acids/metabolism , Epoxide Hydrolases/genetics , Insulin/physiology , Adult , Arachidonic Acids/blood , Body Mass Index , DNA/chemistry , DNA/genetics , Epoxide Hydrolases/metabolism , Female , Genetic Variation , Genotype , Glucose Clamp Technique , Humans , Insulin/metabolism , Insulin Resistance , Insulin Secretion , Male , Middle Aged , Polymerase Chain Reaction , Statistics, Nonparametric , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...